Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7KP1

CD1a-42:2 SM binary complex

Summary for 7KP1
Entry DOI10.2210/pdb7kp1/pdb
DescriptorT-cell surface glycoprotein CD1a, Beta-2-microglobulin, sphingomyelin, ... (5 entities in total)
Functional Keywordscd1, antigen presentation, lipid, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight45903.88
Authors
Wegrecki, M.,Le Nours, J.,Rossjohn, J. (deposition date: 2020-11-10, release date: 2021-05-05, Last modification date: 2024-11-13)
Primary citationCotton, R.N.,Wegrecki, M.,Cheng, T.Y.,Chen, Y.L.,Veerapen, N.,Le Nours, J.,Orgill, D.P.,Pomahac, B.,Talbot, S.G.,Willis, R.,Altman, J.D.,de Jong, A.,Van Rhijn, I.,Clark, R.A.,Besra, G.S.,Ogg, G.,Rossjohn, J.,Moody, D.B.
CD1a selectively captures endogenous cellular lipids that broadly block T cell response.
J.Exp.Med., 218:-, 2021
Cited by
PubMed Abstract: We optimized lipidomics methods to broadly detect endogenous lipids bound to cellular CD1a proteins. Whereas membrane phospholipids dominate in cells, CD1a preferentially captured sphingolipids, especially a C42, doubly unsaturated sphingomyelin (42:2 SM). The natural 42:2 SM but not the more common 34:1 SM blocked CD1a tetramer binding to T cells in all human subjects tested. Thus, cellular CD1a selectively captures a particular endogenous lipid that broadly blocks its binding to TCRs. Crystal structures show that the short cellular SMs stabilized a triad of surface residues to remain flush with CD1a, but the longer lipids forced the phosphocholine group to ride above the display platform to hinder TCR approach. Whereas nearly all models emphasize antigen-mediated T cell activation, we propose that the CD1a system has intrinsic autoreactivity and is negatively regulated by natural endogenous inhibitors selectively bound in its cleft. Further, the detailed chemical structures of natural blockers could guide future design of therapeutic blockers of CD1a response.
PubMed: 33961028
DOI: 10.1084/jem.20202699
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.02 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon